Overview

Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

Status:
Withdrawn

Trial end date:
2011-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the role and effectiveness of conversion to sirolimus versus CNI reduction in renal transplant patients with prostate cancer.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

St. Joseph's Healthcare Hamilton

Treatments:

Calcineurin Inhibitors
Cyclosporine
Cyclosporins
Everolimus
Sirolimus
Tacrolimus